Cargando…
Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
The objective of the present study was to develop bilayer tablets of atorvastatin and atenolol that are characterized by initial fast-release of atorvastatin in the stomach and comply with the release requirements of sustained-release of atenolol. An amorphous, solvent evaporation inclusion complex...
Autores principales: | Dey, Sanjay, Chattopadhyay, Sankha, Mazumder, Bhaskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909979/ https://www.ncbi.nlm.nih.gov/pubmed/24527446 http://dx.doi.org/10.1155/2014/396106 |
Ejemplares similares
-
Formulation and Evaluation of Mouth Disintegrating Tablets of Atenolol and Atorvastatin
por: Sarfraz, R. M., et al.
Publicado: (2015) -
Formulation of Modified-Release Bilayer Tablets of Atorvastatin and Ezetimibe: An In-Vitro and In-Vivo Analysis
por: Mubeen, Iqra, et al.
Publicado: (2022) -
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl
por: El Nabarawi, Mohamed A, et al.
Publicado: (2017) -
Formulation and optimization of mucoadhesive bilayer buccal tablets of atenolol using simplex design method
por: Shirsand, SB, et al.
Publicado: (2012) -
Formulation and evaluation of bilayer tablet for bimodal release of venlafaxine hydrochloride
por: Momin, Munira M., et al.
Publicado: (2015)